Granlen LLC is a multinational chemistry-based contract research organization that offers an integrated discovery and development platform for the biotech and pharmaceutical industries. Our state of the art research facilities are located in Zhengzhou, China, the transportation and business central garden city. With management in San Diego and China, and a commitment to total quality excellence, we can rapidly adjust directions to meet client's needs. Our world-class chemistry and related teams offers made to order compound libraries, hit-to-lead optimization, medicinal chemistry, and a wide range of chemistry related services including custom synthesis, intermediates, reference compounds, metabolites and impurities, route scouting, process development, and scale-up as well as analytical method development, quality control and others for IND preparation.

What sets Granlen apart is our commitment to excellence in everything that we do and our personal approach to collaborative research. "The Reliability" is at the heart of all that we do and is the standard we hold for all client interaction. Together with our solid infrastructure we provide services in a timely, precise, and well-documented fashion that adhere to the highest industry standards. Our world-class teams are committed to exceeding your expectations and becoming your partner of choice for chemistry-based discovery and development.

Granlen has in-house teams trained in:
• Modern Organic Synthesis
• Total Synthesis of Natural Products
• Medicinal Chemistry
• Bioorganic Chemistry
• Combinatorial Chemistry
• Heterocyclic and Macrocyclic Chemistry
• Nucleosides, Nucleotides, and Nucleic Acids
• Process Development and Large Scale Synthesis
• New Drug Discovery and Development
• Formulation
• Immuno-chemistry
• Computer-Aided Drug Design
• Analysis and stability studies
• Biology
• In vitro & in vivo PK Studies
• Pharmacology and Toxicology Studies

Granlen's executives have been trained in US and have more than 50-years working and management experiences in academy and Biotech/Pharmaceutical industries. Our executives have experiences for the whole process of drug discovery and development from scratch to multi-IND approvals which would greatly accelerate our clients' success. Our scientists have a strong history of collaborative research and impressive track records in providing global pharmaceutical and biotechnology companies a broad range of integrated services for drug discovery and development.

Granlen's goal is to provide high quality, reliable, and cost-effective services to our global clients. By using Granlen's services, our clients will greatly increase their capabilities and productivity in drug discovery and development toward IND approval. Granlen is committed total quality excellence in order to exceed clients' expectations and speed clients toward success.